FDA Deploys 'Elsa' AI Tool to Accelerate Medical Device Reviews Amid Budget Cuts
The FDA's new AI tool, CDRH-GPT, still in beta, faces significant issues such as bugs, connectivity problems, and inaccuracies, raising concerns about rushing AI deployment in medical device review processes amid staff layoffs and safety considerations.